Viridian Therapeutics, Inc.
Biotechnology ResearchView the employees at
Viridian Therapeutics, Inc.-
Tony Casciano Chief Commercial Officer, Viridian Therapeutics
-
Greater Boston
-
Rising Star
Angela Doyle Sr. Clinical Trial Manager-
Top 10%
Steve Graunke Associate Director - Development - Viridian Therapeutics-
Greater Boston
-
Top 5%
Lucy Weng Sr. Quality Operations Manager-
Greater Boston
-
Top 5%
Matt Fearer Vice President, Internal & External Communications at Viridian Therapeutics-
Top 1%
Overview
Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian's most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Waltham, Massachusetts.
-